Akebia Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2019 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Akebia Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2019 to 2023.
  • Akebia Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 210M shares, a 11.7% increase year-over-year.
  • Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 187M shares, a 2.56% increase from 2022.
  • Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 183M shares, a 10.1% increase from 2021.
  • Akebia Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 166M shares, a 19.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 187M +4.68M +2.56% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 183M +16.8M +10.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 166M +27.5M +19.9% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-08-28
2020 138M +20.1M +16.9% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-08-28
2019 118M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.